Combined Cognitive-Behavioral Therapy and Placebo Treatment for Patients with Depression: A Follow-Up Assessment

References

• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th. Washington: American Psychiatric Publishing; 2013. doi:10.1176/appi.books.9780890425596
   Google Scholar
• Butler AC, Chapman JE, Forman EM, Beck AT. The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clin Psychol Rev. 2006;26:17–31. doi:10.1016/j.cpr.2005.07.003
   PubMed Web of Science ®Google Scholar
• Cuijpers P, Hollon SD, van Straten A, Bockting C, Berking M, Andersson G. Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis. BMJ Open. 2013;3:e002542. doi:10.1136/bmjopen-2012-002542
   PubMed Web of Science ®Google Scholar
• Hollon SD, Cohen ZD, Singla DR, Andrews PW. Recent developments in the treatment of depression. Behav Ther. 2019;50:257–269. doi:10.1016/j.beth.2019.01.002
   PubMed Web of Science ®Google Scholar
• Mayberg HS, Silva JA, Brannan SK. The functional neuroanatomy of the placebo effect. Am J Psychiatry. 2002;159:728–737. doi:10.1176/appi.ajp.159.5.728
   PubMed Web of Science ®Google Scholar
• Sonawalla SB, Rosenbaum JF. Placebo response in depression. Dialogues Clin Neurosci. 2002;4:105–113.
   PubMedGoogle Scholar
• Kirsch I. Placebo effect in the treatment of depression and anxiety. Front Psychiatry. 2019;10:407. doi:10.3389/fpsyt.2019.00407
   PubMed Web of Science ®Google Scholar
• Peciña M, Bohnert ASB, Sikora M, et al. Association between placebo-activated neural systems and antidepressant responses: neurochemistry of placebo effects in major depression. JAMA Psychiatr. 2015;72:1087–1094. doi:10.1001/jamapsychiatry.2015.1335
   PubMed Web of Science ®Google Scholar
• Stolk P, Ten Berg MJ, Hemels ME, Einarson TR. Meta-analysis of placebo rates in major depressive disorder trials. Ann Pharmacother. 2003;37:1891–1899. doi:10.1345/aph.1D172
   PubMed Web of Science ®Google Scholar
• Shea MT, Elkin I, Imber SD, Sotsky SM, Watkins JT, Collins JF. Course of depressive symptoms over follow-up: findings from the National Institute of Mental Health Treatment of Depression Collaborative Research Program. Arch Gen Psychiatry. 1992;49:782–787. doi:10.1001/archpsyc.1992.01820100026006
   PubMed Web of Science ®Google Scholar
• Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet. 2003;361:653–661. doi:10.1016/S0140-6736(03)12599-8
   PubMed Web of Science ®Google Scholar
• Sim K, Lau WK, Sim J, Sum MY, Baldessarini RJ. Prevention of relapse and recurrence in adults with major depressive disorder: systematic review and meta-analyses of controlled trials. Int J Neuropsychopharmacol. 2015;19:1–13. doi:10.1093/ijnp/pyv076
   Web of Science ®Google Scholar
• Jurinec N, Schienle A. Utilizing placebos to leverage effects of cognitive-behavioral therapy in patients with depression. J Affect Disord. 2020;277:779–784. doi:10.1016/j.jad.2020.08.087
   PubMed Web of Science ®Google Scholar
• World Health Organization. The ICD-10 classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines; 2004. Geneva: WHO. Available from: https://apps.who.int/iris/handle/10665/37958. Accessed February 15, 2021
   Google Scholar
• Lewinsohn PM, Antonuccio DO, Breckenridge JS, Teri L. The Coping with Depression Course. Eugene: Castalia; 1984.
   Google Scholar
• Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996.
   Google Scholar
• Enck P, Zipfel S. Placebo effects in psychotherapy: a framework. Front Psychiatry. 2019;10:1–12. doi:10.3389/fpsyt.2019.00456
   PubMed Web of Science ®Google Scholar
• Kelley JM, Kaptchuk TJ, Cusin C, Lipkin S, Fava M. Open-label placebo for major depressive disorder: a pilot randomized controlled trial. Psychother Psychosom. 2012;81:312–314. doi:10.1159/000337053
   PubMed Web of Science ®Google Scholar
• Charlesworth. JEG, Petkovic G, Kelley JM, et al. Effects of placebos without deception compared with no treatment: a systematic review and meta-analysis. Evid Based Med. 2017;10:97–107. doi:10.1111/jebm.12251
   Google Scholar
• Kanfer FH, Schefft BK. Self-management therapy in clinical practice. In: Jacobson JS, editor. Psychotherapist in Clinical Practice: Cognitive and Behavioral Perspectives. New York: Guilford Press; 1987:10–77.
   Google Scholar
• Iovieno N, Tedeschini E, Levkovitz Y, Ameral VE, Papakostas GI. Does the frequency of follow-up assessments affect clinical trial outcomes? A meta-analysis and meta-regression of placebo-controlled randomized trials. Int J Neuropsychopharm. 2012;15:289–296. doi:10.1017/S1461145711000666
   PubMed Web of Science ®Google Scholar
• Jarrett RB, Thase ME. Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetine- and pill placebo-controlled, randomized trial with 2-year follow-up. Contemp Clin Trials. 2010;31:355–377. doi:10.1016/j.cct.2010.04.004
   PubMed Web of Science ®Google Scholar
• Jarrett RB, Minhajuddin A, Gershenfeld H, Friedman ES, Thase ME. Preventing depressive relapse and recurrence in higher-risk cognitive therapy responders: a randomized trial of continuation phase cognitive therapy, fluoxetine, or matched pill placebo. JAMA Psychiatr. 2013;70:11. doi:10.1001/jamapsychiatry.2013.1969
   Web of Science ®Google Scholar
• Höfler C, Schienle A. Placebo effects on the quantity and quality of relaxation training. J Health Psychol. 2020;1–8. doi:10.1177/1359105320954238
   Web of Science ®Google Scholar
• Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci. 2015;16:403–418. doi:10.1038/nrn3976
   PubMed Web of Science ®Google Scholar